Bathi sadurunge mbayar bunga, pajak, lan amortisasi: Nautilus Bio (NAUT)
Nautilus Biotechnology is developing robotic AI laboratories, although financial stability currently depends on R&D investments. Operating cash flow before interest and taxes reflects profit dynamics, where 0.00 captures the current value of the indicator. High-throughput proteome mapping provides the company with immense market power due to the inelastic demand for protein analysis.
Nautilus Bio (NAUT) - rincian metrik lan laporan keuangan
- nilai saham lan prakiraan konsensus rega:
- indikator kapitalisasi bursa perusahaan:
- rincian valuasi buku bisnis:
- indikator total utang lan likuiditas perusahaan:
Rasio Kabeh Utang marang Dana Pribadi Nautilus Biotechnology|NAUT - Utang jangka dawa marang modal|Utang jangka cendhak marang ekuitas Nautilus Biotechnology, Inc.|NAUT - Gunggung utang perusahaan|Utang-utang marang aset resik Nautilus Biotechnology|NAUT - Utang jangka dawa perusahaan|Utang jangka cendhak Nautilus Biotechnology|Rasio likuiditas perantara nautilus.bio
- data bathi bisnis lan rasio investasi:
NAUT - Bathi resik|Bathi resik sing dikarepake Nautilus Biotechnology|NAUT - Pangali P/E|Prakiraan rega marang bathi Nautilus Biotechnology, Inc.|NAUT - Pangali PEG|Nilai bisnis marang bathi operasional sadurunge panyusutan Nautilus Biotechnology|NAUT - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi saben saham sajrone 12 wulan pungkasan Nautilus Biotechnology|NAUT - Bathi saben saham sajrone rolas wulan pungkasan|Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan nautilus.bio|NAUT - Wutah bathi saben saham ing taun lumaku|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Nautilus Biotechnology
Ringkesan analitik perusahaan:NAUT Nautilus Biotechnology
This indicator measures net cash flow from operating activities before depreciation and interest, allowing for an assessment of the business's internal efficiency regardless of debt load. By analyzing the EBITDA chronology, an investor can see how the liquidity of Nautilus Biotechnology (NAUT) depends on the adoption rates of proteomic platforms and the company's ability to convert scientific demand into actual operating income.
Pesaing Nautilus Biotechnology (NAUT)
Pendapatan operasional sadurunge ngurangi amortisasi Tempus (TEM)|QGEN - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|IONS: Bathi sadurunge mbayar bunga, pajak, lan amortisasi|RGEN (Repligen) - Bathi operasional sadurunge ngurangi amortisasi|Avidity Biosciences Inc (RNA) - Bathi operasional EBITDA|Bathi sadurunge mbayar bunga, pajak, lan amortisasi CRISPR Therapeutics Corp|GeneDx Corp (WGS) - Pendapatan operasional sadurunge ngurangi amortisasi|Bathi operasional sadurunge ngurangi amortisasi RARE (Ultragenyx Pharmaceutical)|BEAM (beamtx.com) - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|Bathi operasional EBITDA SRPT (Sarepta)|Twist Bioscience Inc - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|10x Genomics Corp - Bathi operasional EBITDA|Pendapatan operasional sadurunge ngurangi amortisasi Intellia Corp NTLA|Stoke Therapeutics (STOK) - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi sadurunge bunga, pajak, lan amortisasi biolifesolutions.com (BLFS)|Bathi operasional sadurunge ngurangi amortisasi WVE|MAZE (Maze Therapeutics, Inc.) - Bathi perusahaan sadurunge pajak, bunga, lan amortisasi|Bathi operasional EBITDA SION|PRME - Bathi sadurunge bunga, pajak, lan amortisasi|Bathi operasional EBITDA TSHA (Taysha Gene Therapies)|QURE - Bathi operasional sadurunge ngurangi amortisasi|MeiraGTx - Bathi operasional EBITDA|Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi RGNX (REGENXBIO Inc)|Solid Bio (SLDB) - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi operasional sadurunge amortisasi OCGN|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Pacific Biosciences|Bathi sadurunge bunga, pajak, lan amortisasi benitec.com BNTC|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Design Therapeutics, Inc. (DSGN)|Bathi sadurunge mbayar bunga, pajak, lan amortisasi RCKT (Rocket Pharma)|Bathi sadurunge mbayar bunga, pajak, lan amortisasi 4D Molecular Therapeutics Inc FDMT|Lexeo Therapeutics Inc. (LXEO) - Bathi sadurunge bunga, pajak, lan amortisasi|Korro Bio, Inc - Bathi operasional EBITDA|Bathi operasional sadurunge potongan amortisasi editasmedicine.com (EDIT)|SLN (Silence Therapeutics plc) - Bathi operasional sadurunge ngurangi amortisasi|Bathi sadurunge bunga, pajak, lan amortisasi ProQR Therapeutics (PRQR)|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Codexis Inc|Bathi operasional sadurunge amortisasi SGMO (Sangamo BioSciences)|Bathi operasional EBITDA MGX|Bathi operasional EBITDA precisionbiosciences.com (DTIL)|Generation Bio - Bathi operasional sadurunge ngurangi amortisasi|Bathi operasional EBITDA Boundless Bio Inc. BOLD|XCUR: Bathi operasional sadurunge ngurangi amortisasi|Imunon, Inc. - Bathi perusahaan sadurunge pajak, bunga, lan amortisasi|PHIO: Bathi operasional EBITDA|Bathi operasional sadurunge amortisasi MBIO|Bathi sadurunge mbayar bunga, pajak, lan amortisasi TransCode Therapeutics Inc.|Bathi operasional sadurunge amortisasi BNGO (Bionano)|Bathi operasional EBITDA APDN|Bathi operasional EBITDA bluebird bio, Inc (BLUE)|Bathi sadurunge mbayar bunga, pajak, lan amortisasi ImmunoPrecise Antibodies Ltd. IPA|OMGA: Bathi operasional sadurunge amortisasi|Singular Genomics - Bathi operasional EBITDA|RGLS - Bathi operasional EBITDA|SYRS (Syros) - Bathi operasional sadurunge ngurangi amortisasi|Telesis Bio, Inc (TBIO) - Bathi operasional EBITDA|Bathi operasional sadurunge ngurangi amortisasi TCON|UBX (unitybiotechnology.com) - Bathi perusahaan sadurunge pajak, bunga, lan amortisasi
